Compare Accenture plc (ACN) vs Canopy Growth Corp (CGC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Accenture plc vs Canopy Growth Corp — how do they compare? Accenture plc trades at $137.69 (market cap $86.98B), while Canopy Growth Corp trades at $0.96 (market cap $404.40M). The key difference: Accenture plc is far larger — about 215.1× Canopy Growth Corp's market cap, and Accenture plc pays a 4.59% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| ACN | CGC | |
|---|---|---|
Market Cap | $86.98B | $404.40M |
Sector | Technology | Health |
52-Week High | $303.33 | $1.92 |
52-Week Low | $124.41 | $0.86 |
Enterprise Value | $85.20B | $343.85M |
Dividend Yield | 4.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Accenture (ACN) trades at $137.19, up 0.17% on the day, with a bearish technical signal from moving averages. The company shows solid fundamentals with a P/E of 11.35, net income margin of 10.66%, and consistent earnings beats in recent quarters. Recent news highlights strategic AI partnerships with TEPCO Solution Advance and AlphaSense, reinforcing its focus on digital transformation services. Operating cash flow strengthened to $11.47 billion in 2025, supporting dividend payments and growth initiatives.
The outlook for ACN is positive, driven by strong analyst sentiment with a consensus price target of $193.92 and 66% buy ratings. Key opportunities include revenue growth from AI adoption and global consulting demand. Risks involve competitive pressures, macroeconomic sensitivity, and execution challenges in integrating new technologies. The stock offers value with reasonable valuation multiples and a track record of profitability.
CGC trades at $0.95, down 5% on the day, with a bearish technical signal and negative earnings momentum after recent quarterly misses. The company reported a net loss of $598.12 million in 2025, with a net income margin of -222.36%, though revenue trends show some stabilization. Cash flow remains negative, and the stock faces Nasdaq listing compliance risks due to its low price, with news highlighting potential for a reverse stock split.
The outlook is highly speculative with significant operational and financial risks. While valuation ratios like P/S of 1.44 and P/B of 0.83 appear modest, persistent losses and high debt levels overshadow any near-term upside. Investor sentiment is mixed among analysts, with a slight hold bias, but the path to profitability remains uncertain amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Accenture plc
Accenture PLC provides management and technology consulting services and solutions. The Company delivers a range of specialized capabilities and solutions to clients across all industries on a worldwide basis. Accenture operates a network of businesses provides consulting, technology, outsourcing, and alliances.
Read more on ACN →About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →
